一项全基因组关联研究确定了2型糖尿病的新风险位置
Robert Sladek1, Ghislain Rocheleau, Johan Rung
1Department of Human Genetics, McGill University and Genome Quebec Innovation Centre, Montreal H3A 1A4, Canada.
Nature
|February 13, 2007
概括
研究人员确定了与2型糖尿病风险相关的四个新的遗传位置. 这项全基因组研究利用高密度数组来分析单核酸多态,进步了我们对复杂遗传特征的理解.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 2型糖尿病是由遗传和环境因素之间的复杂相互作用引起的.
- 许多导致2型糖尿病的遗传变异仍然未被确定.
- 基因定型技术的进步使得大规模的遗传关联研究成为可能.
研究的目的:
- 识别与2型糖尿病相关的新型遗传变异.
- 用全基因组关联研究 (GWAS) 来阐明复杂的特征.
- 在独立的队列中验证发现.
主要方法:
- 在法国的病例对照队列中,对392,935个单核酸多形态的系统基因定型.
- 全基因组关联研究 (GWAS) 方法.
- 在第二个队列中复制重要发现.
主要成果:
- 鉴定了四个与2型糖尿病风险相关的新型遗传位置.
- 证实了与TCF7L2基因的相关性.
- 与SLC30A8,IDE-KIF11-HHEX和EXT2-ALX4位点发现了重要的关联.
结论:
- 鉴定到的基因变异解释了2型糖尿病风险的很大一部分.
- 这项研究提供了使用全基因组方法研究复杂遗传疾病的原则证明.
- 发现新的位点为人们提供了关于β细胞功能和2型糖尿病的发展的见解.
相关概念视频
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Type I Diabetes I: Introduction
64
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
64
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36


